back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-03-09 11:42 Tx date 2022-01-20 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,135 vol |
28,364 | |
| Filed 2022-03-09 11:41 Tx date 2022-01-20 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-6,458 vol |
14,856 | |
| Filed 2022-03-09 11:40 Tx date 2022-01-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+6,458 vol |
26,449 | |
| Filed 2022-03-09 11:38 Tx date 2022-01-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+9,533 vol |
61,272 | |
| Filed 2022-03-09 11:37 Tx date 2022-01-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+6,459 vol |
53,719 | |
| Filed 2022-03-09 11:35 Tx date 2022-01-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,303 vol |
58,378 | |
| Filed 2022-03-09 11:32 Tx date 2022-01-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+9,995 vol |
69,610 | |
| Filed 2022-03-09 11:22 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-26,750 vol |
26,750 | |
| Filed 2022-03-09 11:20 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-26,750 vol |
26,750 | |
| Filed 2022-03-09 11:17 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Peters, Brian
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-26,750 vol |
26,750 | |
| Filed 2021-12-29 17:10 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-15,774 vol |
||
| Filed 2021-12-29 17:07 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-15,807 vol |
||
| Filed 2021-12-29 17:05 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Peters, Brian
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-15,932 vol |
||
| Filed 2022-03-08 16:28 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,266 vol |
19,991 | |
| Filed 2021-12-29 17:02 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,149 vol |
||
| Filed 2022-01-13 09:53 Tx date 2022-01-10 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,135 vol |
23,229 | |
| Filed 2022-01-13 09:52 Tx date 2022-01-10 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-5,135 vol |
14,973 | |
| Filed 2022-01-04 10:57 Tx date 2021-12-31 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,700
+5,000 vol $2.54 each |
534,263 | |
| Filed 2021-12-29 17:10 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+15,774 vol |
61,116 | |
| Filed 2021-12-29 17:10 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-15,774 vol |
37,726 | |
| Filed 2021-12-29 17:08 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+15,807 vol |
47,190 | |
| Filed 2021-12-29 17:07 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-15,807 vol |
37,693 | |
| Filed 2021-12-29 17:05 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Peters, Brian
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+15,932 vol |
47,752 | |
| Filed 2021-12-29 17:05 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Peters, Brian
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-15,932 vol |
37,568 | |
| Filed 2021-12-29 17:03 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,149 vol |
18,094 | |
| Filed 2021-12-29 17:02 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,149 vol |
20,108 | |
| Filed 2021-12-28 15:03 Tx date 2021-12-20 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Kerry Bakewell - RRSP (Control or Direction)
|
Common Shares
97 - Other
|
+53,500 vol |
85,935 | |
| Filed 2021-12-20 16:32 Tx date 2021-12-17 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,750
+5,000 vol $2.55 each |
529,263 | |
| Filed 2021-12-07 10:42 Tx date 2021-12-06 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Peters, Brian
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$277.33
+100 vol $2.77 each |
31,820 | |
| Filed 2021-12-01 08:39 Tx date 2021-11-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Peters, Brian
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$496.96
+175 vol $2.84 each |
31,720 | |
| Filed 2021-11-30 17:26 Tx date 2021-11-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+160,500 vol |
524,263 | |
| Filed 2021-11-30 17:25 Tx date 2021-11-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-160,500 vol |
160,500 | |
| Filed 2021-11-18 16:23 Tx date 2021-11-10 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Wildgoose Brown, Ian Craig
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+18,000 vol |
18,000 | |
| Filed 2021-11-18 16:11 Tx date 2021-11-10 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Wildgoose Brown, Ian Craig
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+36,000 vol |
36,000 | |
| Filed 2021-11-18 16:07 Tx date 2021-11-08 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Wildgoose Brown, Ian Craig
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-11-18 16:06 Tx date 2021-11-08 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Wildgoose Brown, Ian Craig
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-11-17 18:22 Tx date 2021-11-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,434
+5,000 vol $2.89 each |
363,763 | |
| Filed 2021-11-12 14:56 Tx date 2021-11-12 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,200
+5,000 vol $3.04 each |
358,763 | |
| Filed 2021-10-05 16:21 Tx date 2021-10-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+5,323 vol |
47,260 | |
| Filed 2021-10-05 16:20 Tx date 2021-09-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+5,323 vol |
||
| Filed 2021-10-05 16:08 Tx date 2021-10-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Pine, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+24,000 vol |
48,000 | |
| Filed 2021-10-05 16:06 Tx date 2021-10-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Adelman, Michael David
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+24,000 vol |
48,000 | |
| Filed 2021-10-05 16:02 Tx date 2021-10-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Common Shares
59 - Exercise for cash
|
$13,231
+4,396 vol $3.01 each |
16,945 | |
| Filed 2021-10-05 16:01 Tx date 2021-10-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-5,322 vol |
21,257 | |
| Filed 2021-10-05 16:01 Tx date 2021-10-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+5,322 vol |
26,579 | |
| Filed 2021-10-05 15:58 Tx date 2021-10-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,189 vol |
51,739 | |
| Filed 2021-10-05 15:56 Tx date 2021-10-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+6,898 vol |
50,075 | |
| Filed 2021-10-05 15:53 Tx date 2021-10-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,539 vol |
59,615 | |
| Filed 2021-10-05 15:52 Tx date 2021-09-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV, L.P. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$175,290
+54,438 vol $3.22 each |
128,607 | |
| Filed 2021-10-05 15:51 Tx date 2021-09-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV (International) L.P. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$4,710
+1,463 vol $3.22 each |
3,456 | |
| Filed 2021-10-05 15:25 Tx date 2021-09-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+5,323 vol |
||
| Filed 2021-10-05 15:25 Tx date 2021-09-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+5,323 vol |
34,101 | |
| Filed 2021-10-05 15:23 Tx date 2021-09-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: Stephen & Kathryn Nelson - RESP (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$2,250
+699 vol $3.22 each |
1,651 | |
| Filed 2021-10-05 15:22 Tx date 2021-09-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$1,500
+466 vol $3.22 each |
104,891 | |
| Filed 2021-10-05 15:22 Tx date 2021-09-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: Kathryn Nelson - RRSP (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$3,001
+932 vol $3.22 each |
2,201 | |
| Filed 2021-10-05 15:20 Tx date 2021-09-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$631.12
+196 vol $3.22 each |
353,763 | |
| Filed 2021-10-05 15:18 Tx date 2021-09-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$631.12
+196 vol $3.22 each |
||
| Filed 2021-10-05 14:57 Tx date 2021-09-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$631.12
+196 vol $3.22 each |
||
| Filed 2021-10-05 14:57 Tx date 2021-09-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$631.12
+196 vol $3.22 each |
353,763 | |
| Filed 2021-09-30 17:02 Tx date 2021-09-28 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Konrad, Marcel Pascal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$967.20
+400 vol $2.42 each |
7,000 | |
| Filed 2021-09-30 17:01 Tx date 2021-09-28 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Konrad, Marcel Pascal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,471
+3,100 vol $2.41 each |
6,600 | |
| Filed 2021-09-24 14:28 Tx date 2021-09-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,000
+5,000 vol $3.00 each |
353,567 | |
| Filed 2021-09-24 14:26 Tx date 2021-09-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$888.00
+300 vol $2.96 each |
21,228 | |
| Filed 2021-09-24 14:26 Tx date 2021-09-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,008
+3,033 vol $2.97 each |
20,928 | |
| Filed 2021-09-23 17:44 Tx date 2021-09-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-5,040 vol |
21,257 | |
| Filed 2021-09-23 17:43 Tx date 2021-09-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-5,040 vol |
||
| Filed 2021-09-23 15:14 Tx date 2021-09-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Common Shares
59 - Exercise for cash
|
+4,012 vol |
12,549 | |
| Filed 2021-09-23 15:13 Tx date 2021-09-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-5,040 vol |
21,257 | |
| Filed 2021-09-23 15:13 Tx date 2021-09-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-5,040 vol |
||
| Filed 2021-09-21 16:25 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
69,731 | |
| Filed 2021-09-21 16:24 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
||
| Filed 2021-09-21 16:23 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
36,398 | |
| Filed 2021-09-21 16:23 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
||
| Filed 2021-09-21 16:22 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
36,398 | |
| Filed 2021-09-21 16:21 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
||
| Filed 2021-09-21 16:19 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
43,065 | |
| Filed 2021-09-21 16:18 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
||
| Filed 2021-09-21 16:17 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
36,398 | |
| Filed 2021-09-21 16:16 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
||
| Filed 2021-09-21 09:11 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
||
| Filed 2021-09-21 09:11 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
36,398 | |
| Filed 2021-09-21 09:10 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+13,159 vol |
41,937 | |
| Filed 2021-09-21 09:08 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
||
| Filed 2021-09-21 09:08 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
36,398 | |
| Filed 2021-09-21 09:08 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+13,159 vol |
26,297 | |
| Filed 2021-09-21 09:06 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
||
| Filed 2021-09-21 09:06 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
43,065 | |
| Filed 2021-09-21 09:05 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+13,159 vol |
43,550 | |
| Filed 2021-09-21 09:04 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
||
| Filed 2021-09-21 09:04 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
69,731 | |
| Filed 2021-09-21 09:03 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+13,159 vol |
43,177 | |
| Filed 2021-09-21 09:00 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
36,398 | |
| Filed 2021-09-21 09:00 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
||
| Filed 2021-09-21 08:57 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+13,159 vol |
51,076 | |
| Filed 2021-09-14 09:28 Tx date 2021-09-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Konrad, Marcel Pascal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,625
+3,500 vol $2.75 each |
3,500 | |
| Filed 2021-09-14 09:28 Tx date 2021-07-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Konrad, Marcel Pascal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-13 09:22 Tx date 2021-09-09 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 6% Unsecured
10 - Acquisition or disposition in the public market
|
+$21,000 vol |
$21,000 | |
| Filed 2021-09-13 08:49 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 6% Unsecured
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-07 11:10 Tx date 2021-08-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,850
+5,000 vol $2.77 each |
17,895 | |
| Filed 2021-08-23 10:43 Tx date 2021-08-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,385
+500 vol $2.77 each |
||
| Filed 2021-08-25 11:34 Tx date 2021-08-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Konrad, Marcel Pascal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+48,000 vol |
48,000 | |
| Filed 2021-08-25 11:33 Tx date 2021-07-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Konrad, Marcel Pascal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-08-25 11:33 Tx date 2021-08-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Konrad, Marcel Pascal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+24,000 vol |
24,000 | |
| Filed 2021-08-25 11:31 Tx date 2021-07-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Konrad, Marcel Pascal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-08-23 10:43 Tx date 2021-08-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,385
+500 vol $2.77 each |
13,395 | |
| Filed 2021-08-23 10:41 Tx date 2021-08-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Pine, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,438
+500 vol $2.88 each |
2,000 | |
| Filed 2021-08-19 15:50 Tx date 2021-08-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,461
+1,588 vol $2.18 each |
45,342 | |
| Filed 2021-08-19 15:49 Tx date 2021-08-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$260.40
+120 vol $2.17 each |
43,754 | |
| Filed 2021-08-19 15:49 Tx date 2021-08-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,333
+2,000 vol $2.17 each |
43,634 | |
| Filed 2021-08-19 15:49 Tx date 2021-08-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,230
+2,000 vol $2.12 each |
41,634 | |
| Filed 2021-08-19 15:47 Tx date 2021-08-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,874
+5,000 vol $2.77 each |
348,567 | |
| Filed 2021-08-19 15:46 Tx date 2021-08-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,435
+500 vol $2.87 each |
343,567 | |
| Filed 2021-07-07 08:29 Tx date 2021-07-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$25,176
+3,536 vol $7.12 each |
37,917 | |
| Filed 2021-07-05 14:26 Tx date 2021-07-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$17,671
+2,482 vol $7.12 each |
28,778 | |
| Filed 2021-07-05 13:05 Tx date 2021-07-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$13,997
+1,966 vol $7.12 each |
8,537 | |
| Filed 2021-07-05 13:04 Tx date 2021-07-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-17,657.60
-2,480 vol $7.12 each |
13,138 | |
| Filed 2021-07-05 13:03 Tx date 2021-07-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$17,657
+2,480 vol $7.12 each |
15,618 | |
| Filed 2021-07-05 13:02 Tx date 2021-07-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$23,702
+3,329 vol $7.12 each |
30,391 | |
| Filed 2021-07-05 13:00 Tx date 2021-07-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$22,306
+3,133 vol $7.12 each |
30,018 | |
| Filed 2021-06-30 14:09 Tx date 2021-06-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,333
+2,500 vol $7.33 each |
343,067 | |
| Filed 2021-06-28 13:47 Tx date 2021-06-28 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,723 vol |
6,571 | |
| Filed 2021-06-28 13:47 Tx date 2021-06-28 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-2,151 vol |
13,138 | |
| Filed 2021-06-28 13:30 Tx date 2021-06-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,390
+2,600 vol $5.92 each |
39,634 | |
| Filed 2021-06-22 18:45 Tx date 2021-06-22 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,780
+1,800 vol $7.10 each |
340,567 | |
| Filed 2021-06-22 15:04 Tx date 2021-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,580
+2,000 vol $7.29 each |
338,767 | |
| Filed 2021-06-22 15:03 Tx date 2021-06-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,240
+1,000 vol $7.24 each |
336,767 | |
| Filed 2021-06-22 15:00 Tx date 2021-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,472
+3,260 vol $7.20 each |
17,057 | |
| Filed 2021-06-22 14:55 Tx date 2021-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Pine, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,615
+500 vol $7.23 each |
1,500 | |
| Filed 2021-06-22 14:50 Tx date 2021-06-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,714
+2,494 vol $5.90 each |
37,034 | |
| Filed 2021-06-22 14:47 Tx date 2021-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,061
+300 vol $6.87 each |
12,895 | |
| Filed 2021-06-22 14:46 Tx date 2021-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,085
+300 vol $6.95 each |
12,595 | |
| Filed 2021-06-22 14:46 Tx date 2021-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,408
+200 vol $7.04 each |
12,295 | |
| Filed 2021-06-22 14:46 Tx date 2021-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,600
+500 vol $7.20 each |
12,095 | |
| Filed 2021-06-22 14:45 Tx date 2021-06-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,000
+1,200 vol $7.50 each |
18,132 | |
| Filed 2021-04-05 11:02 Tx date 2021-04-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,958 vol |
4,848 | |
| Filed 2021-04-05 11:01 Tx date 2021-04-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-2,242 vol |
15,289 | |
| Filed 2021-04-05 11:00 Tx date 2021-04-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+2,242 vol |
17,531 | |
| Filed 2021-04-05 10:59 Tx date 2021-04-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+3,008 vol |
27,062 | |
| Filed 2021-04-05 10:57 Tx date 2021-04-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+2,831 vol |
26,885 | |
| Filed 2021-04-05 10:56 Tx date 2021-04-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+2,242 vol |
26,296 | |
| Filed 2021-04-05 10:55 Tx date 2021-04-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+3,195 vol |
34,381 | |
| Filed 2021-03-31 15:38 Tx date 2021-03-31 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Pine, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,220
+1,000 vol $6.22 each |
1,000 | |
| Filed 2021-03-31 15:37 Tx date 2020-09-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Pine, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-15 11:04 Tx date 2021-03-11 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,739
+700 vol $6.77 each |
335,767 | |
| Filed 2021-03-08 17:47 Tx date 2021-03-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,549
+1,500 vol $5.70 each |
34,540 | |
| Filed 2021-03-08 17:47 Tx date 2021-03-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,700
+1,500 vol $5.80 each |
33,040 | |
| Filed 2021-03-08 17:46 Tx date 2021-03-08 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,549
+1,500 vol $5.70 each |
||
| Filed 2021-03-08 17:46 Tx date 2021-03-08 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,700
+1,500 vol $5.80 each |
||
| Filed 2021-03-08 16:16 Tx date 2021-03-08 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,549
+1,500 vol $5.70 each |
||
| Filed 2021-03-08 16:16 Tx date 2021-03-08 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,549
+1,500 vol $5.70 each |
34,540 | |
| Filed 2021-03-08 16:15 Tx date 2021-03-08 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,700
+1,500 vol $5.80 each |
||
| Filed 2021-03-08 16:15 Tx date 2021-03-08 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,700
+1,500 vol $5.80 each |
33,040 | |
| Filed 2021-03-08 16:13 Tx date 2021-03-08 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,244
+300 vol $7.48 each |
335,067 | |
| Filed 2021-03-08 16:13 Tx date 2021-03-08 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,891
+3,500 vol $7.40 each |
334,767 | |
| Filed 2021-02-25 11:51 Tx date 2021-02-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III (International), L.P. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$65,018
+9,661 vol $6.73 each |
9,661 | |
| Filed 2021-02-25 11:51 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III (International), L.P. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-25 11:50 Tx date 2021-02-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III (International), L.P. (Indirect Ownership)
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+4,830 vol |
4,830 | |
| Filed 2021-02-25 11:49 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III (International), L.P. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-25 11:49 Tx date 2021-02-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III, L.P. (Indirect Ownership)
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+145,170 vol |
145,170 | |
| Filed 2021-02-25 11:47 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III, L.P. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-25 11:47 Tx date 2021-02-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III, L.P. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$1,953,981
+290,339 vol $6.73 each |
290,339 | |
| Filed 2021-02-25 11:46 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III, L.P. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-24 10:37 Tx date 2021-02-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$75,376
+11,200 vol $6.73 each |
43,556 | |
| Filed 2021-02-24 10:36 Tx date 2021-02-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+5,600 vol |
9,640 | |
| Filed 2020-12-23 12:27 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,080 vol |
10,080 | |
| Filed 2020-12-23 12:26 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,080 vol |
||
| Filed 2020-12-23 12:23 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+15,531 vol |
31,540 | |
| Filed 2020-12-23 12:22 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-26,750 vol |
53,500 | |
| Filed 2020-12-23 12:21 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+15,544 vol |
31,383 | |
| Filed 2020-12-23 12:20 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-26,750 vol |
53,500 | |
| Filed 2020-12-23 12:19 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Peters, Brian
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+15,549 vol |
31,545 | |
| Filed 2020-12-23 12:18 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Peters, Brian
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-26,750 vol |
53,500 | |
| Filed 2020-12-23 12:09 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,080 vol |
10,080 | |
| Filed 2020-12-23 12:08 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-12-23 12:08 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+5,040 vol |
31,186 | |
| Filed 2020-12-23 12:05 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,080 vol |
10,080 | |
| Filed 2020-12-23 12:03 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-12-23 12:03 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+5,040 vol |
24,054 | |
| Filed 2020-12-23 12:00 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,080 vol |
43,413 | |
| Filed 2020-12-23 11:59 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+5,040 vol |
24,054 | |
| Filed 2020-12-23 11:50 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,080 vol |
16,747 | |
| Filed 2020-12-23 11:48 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+5,040 vol |
24,054 | |
| Filed 2020-12-23 11:45 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,080 vol |
10,080 | |
| Filed 2020-12-23 11:45 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,080 vol |
||
| Filed 2020-12-23 11:44 Tx date 2019-06-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-12-23 11:43 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,071 vol |
2,890 | |
| Filed 2020-12-23 11:42 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,266 vol |
15,289 | |
| Filed 2020-12-23 11:41 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+5,040 vol |
16,555 | |
| Filed 2020-10-30 16:39 Tx date 2020-10-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Pine, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+24,000 vol |
24,000 | |
| Filed 2020-10-30 16:39 Tx date 2020-09-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Pine, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-10-30 16:38 Tx date 2020-10-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Adelman, Michael David
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+24,000 vol |
24,000 | |
| Filed 2020-10-30 16:34 Tx date 2020-05-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Adelman, Michael David
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-10-30 16:26 Tx date 2020-10-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Adelman, Michael David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$183,840
+48,000 vol $3.83 each |
48,000 | |
| Filed 2020-10-30 16:24 Tx date 2020-05-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Adelman, Michael David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-10-30 16:07 Tx date 2020-10-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Pine, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$183,840
+48,000 vol $3.83 each |
48,000 | |
| Filed 2020-10-30 16:05 Tx date 2020-09-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Pine, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-08-28 07:53 Tx date 2020-08-27 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$320.00
+100 vol $3.20 each |
16,009 | |
| Filed 2020-08-26 15:32 Tx date 2020-08-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+10,126 vol |
19,014 | |
| Filed 2020-08-26 15:31 Tx date 2020-08-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+10,126 vol |
||
| Filed 2020-08-26 15:30 Tx date 2020-08-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+13,924 vol |
26,146 | |
| Filed 2020-08-26 15:29 Tx date 2020-08-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+13,924 vol |
||
| Filed 2020-08-26 15:24 Tx date 2020-08-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+5,063 vol |
11,515 | |
| Filed 2020-08-26 15:22 Tx date 2020-08-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+10,126 vol |
19,014 | |
| Filed 2020-08-26 15:20 Tx date 2020-08-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Mueller, Mike
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+10,126 vol |
19,014 | |
| Filed 2020-08-26 11:48 Tx date 2020-08-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+10,126 vol |
19,014 | |
| Filed 2020-08-26 11:48 Tx date 2020-08-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gravel, Benoit
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+10,126 vol |
||
| Filed 2020-08-26 11:45 Tx date 2020-08-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+13,924 vol |
||
| Filed 2020-08-26 11:45 Tx date 2020-08-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+13,924 vol |
26,146 | |
| Filed 2020-06-29 15:56 Tx date 2020-06-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,819 vol |
1,819 | |
| Filed 2020-06-29 15:55 Tx date 2020-06-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,150 vol |
||
| Filed 2020-06-29 15:16 Tx date 2020-06-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,150 vol |
||
| Filed 2020-06-29 15:15 Tx date 2019-06-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-06-29 15:15 Tx date 2020-06-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-2,150 vol |
6,452 | |
| Filed 2020-05-29 13:42 Tx date 2020-05-26 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
$-17,152.80
-6,126 vol $2.80 each |
11,595 | |
| Filed 2020-05-29 13:41 Tx date 2020-05-26 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$17,152
+6,126 vol $2.80 each |
7,571 | |
| Filed 2020-04-04 21:20 Tx date 2020-03-31 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV, L.P. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$175,291
+74,169 vol $2.36 each |
74,169 | |
| Filed 2020-04-04 21:19 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV, L.P. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-04-04 21:19 Tx date 2020-03-31 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV (International) L.P. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$4,710
+1,993 vol $2.36 each |
1,993 | |
| Filed 2020-04-04 21:17 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV (International) L.P. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-04-04 17:49 Tx date 2020-03-31 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$1,498
+634 vol $2.36 each |
104,425 | |
| Filed 2020-04-04 17:48 Tx date 2020-03-31 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: Stephen & Kathryn Nelson - RESP (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$2,249
+952 vol $2.36 each |
952 | |
| Filed 2020-04-04 17:46 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: Stephen & Kathryn Nelson - RESP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-04-04 17:46 Tx date 2020-03-31 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: Kathryn Nelson - RRSP (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$2,999
+1,269 vol $2.36 each |
1,269 | |
| Filed 2020-04-04 17:34 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: Kathryn Nelson - RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-03-24 15:20 Tx date 2020-03-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,306
+1,900 vol $1.74 each |
56,935 | |
| Filed 2020-03-24 15:20 Tx date 2020-03-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$173.00
+100 vol $1.73 each |
55,035 | |
| Filed 2020-03-24 15:19 Tx date 2020-03-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,000
+4,000 vol $1.50 each |
54,935 | |
| Filed 2020-03-13 20:10 Tx date 2020-03-10 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-500 vol |
0 | |
| Filed 2020-03-13 20:09 Tx date 2020-03-02 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,925
+500 vol $3.85 each |
500 | |
| Filed 2020-03-13 17:07 Tx date 2020-03-11 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,000
+2,000 vol $3.00 each |
50,935 | |
| Filed 2020-03-10 13:10 Tx date 2020-02-29 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-25,400 vol |
0 | |
| Filed 2020-03-10 13:09 Tx date 2020-02-28 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,800
+800 vol $3.50 each |
25,400 | |
| Filed 2020-03-10 13:09 Tx date 2020-02-28 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,940
+500 vol $3.88 each |
24,600 | |
| Filed 2020-03-10 13:08 Tx date 2020-02-27 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,500
+1,000 vol $3.50 each |
24,100 | |
| Filed 2020-03-10 13:08 Tx date 2020-02-27 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,984
+1,200 vol $3.32 each |
23,100 | |
| Filed 2020-03-10 13:06 Tx date 2020-02-26 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,984
+1,200 vol $3.32 each |
21,900 | |
| Filed 2020-03-10 13:05 Tx date 2020-02-26 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,650
+500 vol $3.30 each |
20,700 | |
| Filed 2020-03-10 13:03 Tx date 2020-02-26 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,745
+500 vol $3.49 each |
20,200 | |
| Filed 2020-03-10 13:00 Tx date 2020-02-26 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,750
+500 vol $3.50 each |
19,700 | |
| Filed 2020-03-10 12:59 Tx date 2020-02-26 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,760
+500 vol $3.52 each |
19,200 | |
| Filed 2020-03-10 12:57 Tx date 2020-02-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,600
+1,000 vol $3.60 each |
18,200 | |
| Filed 2020-03-10 12:57 Tx date 2020-02-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,850
+500 vol $3.70 each |
18,700 | |
| Filed 2020-03-10 12:54 Tx date 2020-02-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,900
+500 vol $3.80 each |
17,200 | |
| Filed 2020-03-10 12:53 Tx date 2020-02-20 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,700
+1,000 vol $3.70 each |
16,700 | |
| Filed 2020-03-10 12:53 Tx date 2020-02-20 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,970
+500 vol $3.94 each |
15,700 | |
| Filed 2020-03-10 12:52 Tx date 2020-02-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$380.00
+100 vol $3.80 each |
15,200 | |
| Filed 2020-03-10 12:52 Tx date 2020-02-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,940
+500 vol $3.88 each |
15,100 | |
| Filed 2020-03-10 12:51 Tx date 2020-02-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,750
+500 vol $3.50 each |
14,600 | |
| Filed 2020-03-10 12:51 Tx date 2020-02-17 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,660
+1,000 vol $3.66 each |
14,100 | |
| Filed 2020-03-10 12:48 Tx date 2020-02-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,750
+1,000 vol $3.75 each |
13,100 | |
| Filed 2020-03-10 12:47 Tx date 2020-02-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,870
+500 vol $3.74 each |
12,100 | |
| Filed 2020-03-10 12:46 Tx date 2020-02-12 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,825
+500 vol $3.65 each |
11,600 | |
| Filed 2020-03-10 12:45 Tx date 2020-02-10 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,077
+300 vol $3.59 each |
11,100 | |
| Filed 2020-03-10 12:44 Tx date 2020-02-07 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$368.00
+100 vol $3.68 each |
10,800 | |
| Filed 2020-03-10 12:42 Tx date 2020-02-06 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,476
+400 vol $3.69 each |
10,700 | |
| Filed 2020-03-10 12:40 Tx date 2020-02-06 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,865
+500 vol $3.73 each |
10,300 | |
| Filed 2020-03-10 12:40 Tx date 2020-02-05 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,700
+2,000 vol $3.35 each |
9,800 | |
| Filed 2020-03-10 12:39 Tx date 2020-02-05 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,695
+500 vol $3.39 each |
7,800 | |
| Filed 2020-03-10 12:38 Tx date 2020-02-05 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,800
+2,000 vol $3.40 each |
7,300 | |
| Filed 2020-03-10 12:33 Tx date 2020-02-05 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,820
+2,000 vol $3.41 each |
5,300 | |
| Filed 2020-03-10 12:33 Tx date 2020-02-05 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,806
+1,100 vol $3.46 each |
3,300 | |
| Filed 2020-03-10 12:32 Tx date 2020-02-05 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$347.00
+100 vol $3.47 each |
2,200 | |
| Filed 2020-03-10 12:32 Tx date 2020-02-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,490
+1,000 vol $3.49 each |
2,100 | |
| Filed 2020-03-10 12:30 Tx date 2020-02-03 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$346.00
+100 vol $3.46 each |
1,100 | |
| Filed 2020-03-10 12:30 Tx date 2020-02-03 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,490
+1,000 vol $3.49 each |
1,000 | |
| Filed 2020-03-09 17:29 Tx date 2020-03-09 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,017
+300 vol $3.39 each |
48,935 | |
| Filed 2020-03-09 17:28 Tx date 2020-03-09 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,980
+4,700 vol $3.40 each |
48,635 | |
| Filed 2020-03-09 17:27 Tx date 2020-03-06 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,480
+2,000 vol $3.74 each |
43,935 | |
| Filed 2020-03-04 17:53 Tx date 2020-03-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,110
+1,800 vol $3.95 each |
41,735 | |
| Filed 2020-03-04 17:50 Tx date 2020-03-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$788.00
+200 vol $3.94 each |
41,935 | |
| Filed 2020-03-04 17:50 Tx date 2020-03-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,020
+1,800 vol $3.90 each |
||
| Filed 2020-03-04 17:45 Tx date 2020-03-03 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,945
+500 vol $3.89 each |
39,935 | |
| Filed 2020-03-04 17:45 Tx date 2020-03-03 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$800.00
+200 vol $4.00 each |
39,435 | |
| Filed 2020-03-04 17:45 Tx date 2020-03-03 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,770
+4,300 vol $3.90 each |
39,235 | |
| Filed 2020-02-04 18:04 Tx date 2020-01-31 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-113,200 vol |
0 | |
| Filed 2020-02-04 16:49 Tx date 2020-01-31 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,750
+2,500 vol $3.50 each |
113,200 | |
| Filed 2020-02-04 16:49 Tx date 2020-01-31 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,490
+1,000 vol $3.49 each |
110,700 | |
| Filed 2020-02-04 16:48 Tx date 2020-01-31 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,450
+1,000 vol $3.45 each |
109,700 | |
| Filed 2020-02-04 16:48 Tx date 2020-01-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$364.00
+100 vol $3.64 each |
108,700 | |
| Filed 2020-02-04 16:47 Tx date 2020-01-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,506
+700 vol $3.58 each |
108,600 | |
| Filed 2020-02-04 16:46 Tx date 2020-01-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,325
+1,500 vol $3.55 each |
107,900 | |
| Filed 2020-02-04 16:45 Tx date 2020-01-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$22,050
+6,300 vol $3.50 each |
106,400 | |
| Filed 2020-02-04 16:45 Tx date 2020-01-29 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$370.00
+100 vol $3.70 each |
100,100 | |
| Filed 2020-02-04 16:45 Tx date 2020-01-29 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,096
+1,400 vol $3.64 each |
100,000 | |
| Filed 2020-02-04 16:44 Tx date 2020-01-27 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,750
+1,000 vol $3.75 each |
98,600 | |
| Filed 2020-02-04 16:44 Tx date 2020-01-27 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,140
+2,200 vol $3.70 each |
97,600 | |
| Filed 2020-02-04 16:43 Tx date 2020-01-27 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,285
+900 vol $3.65 each |
95,400 | |
| Filed 2020-02-04 16:43 Tx date 2020-01-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,845
+500 vol $3.69 each |
94,500 | |
| Filed 2020-02-04 16:42 Tx date 2020-01-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,015
+1,100 vol $3.65 each |
94,000 | |
| Filed 2020-02-04 16:42 Tx date 2020-01-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,770
+1,000 vol $3.77 each |
92,900 | |
| Filed 2020-02-04 16:41 Tx date 2020-01-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$14,625
+3,900 vol $3.75 each |
91,900 | |
| Filed 2020-02-04 16:41 Tx date 2020-01-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$374.00
+100 vol $3.74 each |
88,000 | |
| Filed 2020-02-04 16:41 Tx date 2020-01-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,400
+2,000 vol $3.70 each |
87,900 | |
| Filed 2020-02-04 16:40 Tx date 2020-01-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,840
+1,900 vol $3.60 each |
85,900 | |
| Filed 2020-02-04 16:40 Tx date 2020-01-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,795
+500 vol $3.59 each |
84,000 | |
| Filed 2020-02-04 16:39 Tx date 2020-01-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$358.00
+100 vol $3.58 each |
83,500 | |
| Filed 2020-02-04 16:39 Tx date 2020-01-20 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,120
+2,400 vol $3.80 each |
83,400 | |
| Filed 2020-02-04 16:38 Tx date 2020-01-20 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$379.00
+100 vol $3.79 each |
81,000 | |
| Filed 2020-02-04 16:38 Tx date 2020-01-20 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,900
+5,000 vol $3.78 each |
80,900 | |
| Filed 2020-02-04 16:37 Tx date 2020-01-20 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,875
+500 vol $3.75 each |
75,900 | |
| Filed 2020-02-04 16:37 Tx date 2020-01-20 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,700
+1,000 vol $3.70 each |
75,400 | |
| Filed 2020-02-04 16:37 Tx date 2020-01-20 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,475
+1,500 vol $3.65 each |
74,400 | |
| Filed 2020-02-04 16:36 Tx date 2020-01-20 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,820
+500 vol $3.64 each |
72,900 | |
| Filed 2020-02-04 16:36 Tx date 2020-01-20 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,160
+600 vol $3.60 each |
72,400 | |
| Filed 2020-02-04 16:35 Tx date 2020-01-17 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,790
+1,000 vol $3.79 each |
71,800 | |
| Filed 2020-02-04 16:35 Tx date 2020-01-17 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,780
+1,000 vol $3.78 each |
70,800 | |
| Filed 2020-02-04 16:35 Tx date 2020-01-17 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,110
+300 vol $3.70 each |
69,800 | |
| Filed 2020-02-04 16:34 Tx date 2020-01-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,960
+800 vol $3.70 each |
69,500 | |
| Filed 2020-02-04 16:01 Tx date 2020-01-15 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$380.00
+100 vol $3.80 each |
68,700 | |
| Filed 2020-02-04 16:01 Tx date 2020-01-15 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,310
+600 vol $3.85 each |
68,600 | |
| Filed 2020-02-04 16:00 Tx date 2020-01-15 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,520
+400 vol $3.80 each |
68,000 | |
| Filed 2020-02-04 16:00 Tx date 2020-01-15 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,875
+500 vol $3.75 each |
67,600 | |
| Filed 2020-02-04 15:59 Tx date 2020-01-15 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,180
+1,400 vol $3.70 each |
67,100 | |
| Filed 2020-02-04 15:59 Tx date 2020-01-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,950
+500 vol $3.90 each |
65,700 | |
| Filed 2020-02-04 15:58 Tx date 2020-01-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,927
+500 vol $3.85 each |
65,200 | |
| Filed 2020-02-04 15:58 Tx date 2020-01-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,925
+500 vol $3.85 each |
64,700 | |
| Filed 2020-02-04 15:57 Tx date 2020-01-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,152
+300 vol $3.84 each |
64,200 | |
| Filed 2020-02-04 15:57 Tx date 2020-01-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,820
+1,000 vol $3.82 each |
63,900 | |
| Filed 2020-02-04 15:57 Tx date 2020-01-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$32,300
+8,500 vol $3.80 each |
62,900 | |
| Filed 2020-02-04 15:56 Tx date 2020-01-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,895
+500 vol $3.79 each |
54,400 | |
| Filed 2020-02-04 15:56 Tx date 2020-01-10 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,870
+500 vol $3.74 each |
53,900 | |
| Filed 2020-02-04 15:55 Tx date 2020-01-10 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$27,750
+7,500 vol $3.70 each |
53,400 | |
| Filed 2020-02-04 15:55 Tx date 2020-01-10 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,225
+2,500 vol $3.69 each |
45,900 | |
| Filed 2020-02-04 15:55 Tx date 2020-01-10 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,340
+2,000 vol $3.67 each |
43,400 | |
| Filed 2020-02-04 15:54 Tx date 2020-01-10 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,260
+2,000 vol $3.63 each |
41,400 | |
| Filed 2020-02-04 15:54 Tx date 2020-01-10 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,590
+1,000 vol $3.59 each |
39,400 | |
| Filed 2020-02-04 15:53 Tx date 2020-01-09 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,180
+1,100 vol $3.80 each |
38,400 | |
| Filed 2020-02-04 15:53 Tx date 2020-01-09 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$35,247
+9,300 vol $3.79 each |
37,300 | |
| Filed 2020-02-04 15:52 Tx date 2020-01-09 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,500
+2,000 vol $3.75 each |
28,000 | |
| Filed 2020-02-04 15:52 Tx date 2020-01-09 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,480
+2,000 vol $3.74 each |
26,000 | |
| Filed 2020-02-04 15:51 Tx date 2020-01-09 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,550
+1,500 vol $3.70 each |
24,000 | |
| Filed 2020-02-04 15:51 Tx date 2020-01-08 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,925
+500 vol $3.85 each |
22,500 | |
| Filed 2020-02-04 15:50 Tx date 2020-01-08 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,500
+2,500 vol $3.80 each |
22,000 | |
| Filed 2020-02-04 15:50 Tx date 2020-01-08 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,306
+1,400 vol $3.79 each |
19,500 | |
| Filed 2020-02-04 15:49 Tx date 2020-01-06 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,730
+4,500 vol $3.94 each |
18,100 | |
| Filed 2020-02-04 15:49 Tx date 2020-01-06 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,202
+1,100 vol $3.82 each |
13,600 | |
| Filed 2020-02-04 15:48 Tx date 2020-01-06 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,810
+1,000 vol $3.81 each |
12,500 | |
| Filed 2020-02-04 15:48 Tx date 2020-01-06 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,740
+2,300 vol $3.80 each |
11,500 | |
| Filed 2020-02-04 15:47 Tx date 2020-01-06 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$758.00
+200 vol $3.79 each |
9,200 | |
| Filed 2020-02-04 15:47 Tx date 2020-01-02 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,600
+2,900 vol $4.00 each |
9,000 | |
| Filed 2020-02-04 15:46 Tx date 2020-01-02 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,379
+2,100 vol $3.99 each |
6,100 | |
| Filed 2020-02-04 15:46 Tx date 2020-01-02 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,960
+2,000 vol $3.98 each |
4,000 | |
| Filed 2020-02-04 15:46 Tx date 2020-01-02 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,092
+1,800 vol $3.94 each |
2,000 | |
| Filed 2020-02-04 15:45 Tx date 2020-01-02 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$786.00
+200 vol $3.93 each |
200 | |
| Filed 2020-02-03 17:29 Tx date 2019-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Shoemaker, Mary
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$303.33
+30,333 vol $0.01 each |
30,333 | |
| Filed 2020-02-03 17:29 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Shoemaker, Mary
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-02-03 17:29 Tx date 2019-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Shoemaker, Mary
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-535.00
-53,500 vol $0.01 each |
160,500 | |
| Filed 2020-02-03 17:27 Tx date 2019-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$159.09
+15,909 vol $0.01 each |
15,909 | |
| Filed 2020-02-03 17:27 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-02-03 17:27 Tx date 2019-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Tate, Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-267.50
-26,750 vol $0.01 each |
80,250 | |
| Filed 2020-02-03 17:25 Tx date 2019-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$158.39
+15,839 vol $0.01 each |
15,839 | |
| Filed 2020-02-03 17:25 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-02-03 17:24 Tx date 2019-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-267.50
-26,750 vol $0.01 each |
80,250 | |
| Filed 2020-02-03 17:22 Tx date 2019-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Peters, Brian
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$159.96
+15,996 vol $0.01 each |
15,996 | |
| Filed 2020-02-03 17:22 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Peters, Brian
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-02-03 17:21 Tx date 2019-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Peters, Brian
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-267.50
-26,750 vol $0.01 each |
80,250 | |
| Filed 2020-01-18 20:00 Tx date 2019-12-31 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-79,100 vol |
0 | |
| Filed 2020-01-18 19:55 Tx date 2019-12-27 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,528
+400 vol $3.82 each |
79,100 | |
| Filed 2020-01-18 19:55 Tx date 2019-12-27 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,830
+1,000 vol $3.83 each |
78,700 | |
| Filed 2020-01-18 19:54 Tx date 2019-12-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,820
+1,000 vol $3.82 each |
77,700 | |
| Filed 2020-01-18 19:53 Tx date 2019-12-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,935
+500 vol $3.87 each |
76,700 | |
| Filed 2020-01-18 19:52 Tx date 2019-12-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$780.00
+200 vol $3.90 each |
76,200 | |
| Filed 2020-01-18 19:52 Tx date 2019-12-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,940
+1,000 vol $3.94 each |
76,000 | |
| Filed 2020-01-18 19:51 Tx date 2019-12-20 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,930
+1,000 vol $3.93 each |
75,000 | |
| Filed 2020-01-18 19:51 Tx date 2019-12-20 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,940
+1,000 vol $3.94 each |
74,000 | |
| Filed 2020-01-18 19:50 Tx date 2019-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,940
+1,000 vol $3.94 each |
73,000 | |
| Filed 2020-01-18 19:49 Tx date 2019-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,850
+1,500 vol $3.90 each |
72,000 | |
| Filed 2020-01-18 19:48 Tx date 2019-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,950
+1,000 vol $3.95 each |
70,500 | |
| Filed 2020-01-18 19:47 Tx date 2019-12-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,925
+1,500 vol $3.95 each |
69,500 | |
| Filed 2020-01-18 19:46 Tx date 2019-12-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,990
+1,000 vol $3.99 each |
68,000 | |
| Filed 2020-01-18 19:45 Tx date 2019-12-17 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$25,137
+6,300 vol $3.99 each |
67,000 | |
| Filed 2020-01-18 19:45 Tx date 2019-12-17 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$398.00
+100 vol $3.98 each |
60,700 | |
| Filed 2020-01-18 19:44 Tx date 2019-12-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,040
+1,000 vol $4.04 each |
60,600 | |
| Filed 2020-01-18 19:44 Tx date 2019-12-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,135
+1,500 vol $4.09 each |
59,600 | |
| Filed 2020-01-18 19:43 Tx date 2019-12-12 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,080
+1,000 vol $4.08 each |
58,100 | |
| Filed 2020-01-18 19:43 Tx date 2019-12-11 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,000
+1,000 vol $4.00 each |
57,100 | |
| Filed 2020-01-18 19:41 Tx date 2019-12-11 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,050
+1,000 vol $4.05 each |
56,100 | |
| Filed 2020-01-18 19:41 Tx date 2019-12-11 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$19,500
+5,000 vol $3.90 each |
55,100 | |
| Filed 2020-01-18 19:40 Tx date 2019-12-10 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,104
+800 vol $3.88 each |
50,100 | |
| Filed 2020-01-18 19:40 Tx date 2019-12-10 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,292
+600 vol $3.82 each |
49,300 | |
| Filed 2020-01-18 19:39 Tx date 2019-12-10 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,700
+2,000 vol $3.85 each |
48,700 | |
| Filed 2020-01-18 19:39 Tx date 2019-12-10 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$25,542
+6,600 vol $3.87 each |
46,700 | |
| Filed 2020-01-18 19:38 Tx date 2019-12-09 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,950
+1,000 vol $3.95 each |
40,100 | |
| Filed 2020-01-18 19:37 Tx date 2019-12-09 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,000
+1,000 vol $4.00 each |
39,100 | |
| Filed 2020-01-18 19:37 Tx date 2019-12-06 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,850
+1,000 vol $3.85 each |
38,100 | |
| Filed 2020-01-18 19:36 Tx date 2019-12-05 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,900
+2,000 vol $3.95 each |
37,100 | |
| Filed 2020-01-18 19:36 Tx date 2019-12-05 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,000
+1,000 vol $4.00 each |
35,100 | |
| Filed 2020-01-18 19:35 Tx date 2019-12-05 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,100
+1,000 vol $4.10 each |
34,100 | |
| Filed 2020-01-18 19:35 Tx date 2019-12-05 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,075
+500 vol $4.15 each |
33,100 | |
| Filed 2020-01-18 19:33 Tx date 2019-12-05 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,800
+2,000 vol $3.90 each |
32,600 | |
| Filed 2020-01-18 19:33 Tx date 2019-12-05 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,890
+1,000 vol $3.89 each |
30,600 | |
| Filed 2020-01-18 19:32 Tx date 2019-12-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,875
+2,900 vol $3.75 each |
29,600 | |
| Filed 2020-01-18 19:31 Tx date 2019-12-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$374.00
+100 vol $3.74 each |
26,700 | |
| Filed 2020-01-18 19:30 Tx date 2019-12-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,250
+5,000 vol $3.65 each |
26,600 | |
| Filed 2020-01-18 19:30 Tx date 2019-12-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,400
+2,000 vol $3.70 each |
21,600 | |
| Filed 2020-01-18 19:27 Tx date 2019-12-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,700
+1,500 vol $3.80 each |
19,600 | |
| Filed 2020-01-18 19:27 Tx date 2019-12-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,800
+2,000 vol $3.90 each |
18,100 | |
| Filed 2020-01-18 19:26 Tx date 2019-12-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,900
+2,000 vol $3.95 each |
16,100 | |
| Filed 2020-01-18 19:25 Tx date 2019-12-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$22,800
+5,700 vol $4.00 each |
14,100 | |
| Filed 2020-01-18 19:25 Tx date 2019-12-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,050
+500 vol $4.10 each |
8,400 | |
| Filed 2020-01-18 19:24 Tx date 2019-12-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,432
+800 vol $4.29 each |
7,900 | |
| Filed 2020-01-18 19:24 Tx date 2019-12-03 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,003
+700 vol $4.29 each |
7,100 | |
| Filed 2020-01-18 19:23 Tx date 2019-12-03 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,075
+500 vol $4.15 each |
6,400 | |
| Filed 2020-01-18 19:23 Tx date 2019-12-03 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,082
+1,800 vol $4.49 each |
5,900 | |
| Filed 2020-01-18 19:22 Tx date 2019-12-03 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$896.00
+200 vol $4.48 each |
4,100 | |
| Filed 2020-01-18 19:22 Tx date 2019-12-02 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,780
+900 vol $4.20 each |
3,900 | |
| Filed 2020-01-18 19:21 Tx date 2019-12-02 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$430.00
+100 vol $4.30 each |
3,000 | |
| Filed 2020-01-18 19:21 Tx date 2019-12-02 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,800
+2,700 vol $4.00 each |
2,900 | |
| Filed 2020-01-18 19:20 Tx date 2019-12-02 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$810.00
+200 vol $4.05 each |
200 | |
| Filed 2019-12-09 09:53 Tx date 2019-12-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,602 vol |
8,602 | |
| Filed 2019-12-09 09:51 Tx date 2019-06-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Gulfo, Adele Madelyn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-12-06 18:30 Tx date 2019-11-29 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-97,100 vol |
0 | |
| Filed 2019-12-06 18:24 Tx date 2019-11-29 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$19,440
+4,800 vol $4.05 each |
97,100 | |
| Filed 2019-12-06 18:23 Tx date 2019-11-29 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,739
+1,400 vol $4.10 each |
92,300 | |
| Filed 2019-12-06 18:20 Tx date 2019-11-28 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,559
+1,600 vol $4.10 each |
90,900 | |
| Filed 2019-12-06 18:19 Tx date 2019-11-28 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,100
+500 vol $4.20 each |
89,300 | |
| Filed 2019-12-06 18:19 Tx date 2019-11-28 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,315
+1,500 vol $4.21 each |
88,800 | |
| Filed 2019-12-06 18:14 Tx date 2019-11-28 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,800
+700 vol $4.00 each |
87,300 | |
| Filed 2019-12-06 18:13 Tx date 2019-11-28 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,120
+500 vol $4.24 each |
86,600 | |
| Filed 2019-12-06 18:12 Tx date 2019-11-27 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,050
+1,000 vol $4.05 each |
86,100 | |
| Filed 2019-12-06 18:07 Tx date 2019-11-27 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,480
+3,200 vol $3.90 each |
85,100 | |
| Filed 2019-12-06 18:07 Tx date 2019-11-27 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,304
+600 vol $3.84 each |
81,900 | |
| Filed 2019-12-06 18:04 Tx date 2019-11-26 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,800
+2,000 vol $3.90 each |
81,300 | |
| Filed 2019-12-06 18:02 Tx date 2019-11-26 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,536
+400 vol $3.84 each |
79,300 | |
| Filed 2019-12-06 18:01 Tx date 2019-11-26 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,550
+3,000 vol $3.85 each |
78,900 | |
| Filed 2019-12-06 17:57 Tx date 2019-11-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$40,425
+10,500 vol $3.85 each |
75,900 | |
| Filed 2019-12-06 17:56 Tx date 2019-11-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,860
+1,000 vol $3.86 each |
65,400 | |
| Filed 2019-12-06 17:55 Tx date 2019-11-22 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,580
+3,000 vol $3.86 each |
64,400 | |
| Filed 2019-12-06 17:55 Tx date 2019-11-22 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,870
+1,000 vol $3.87 each |
61,400 | |
| Filed 2019-12-06 17:54 Tx date 2019-11-22 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,460
+4,500 vol $3.88 each |
60,400 | |
| Filed 2019-12-06 17:53 Tx date 2019-11-20 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,328
+600 vol $3.88 each |
55,900 | |
| Filed 2019-12-06 17:53 Tx date 2019-11-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,552
+400 vol $3.88 each |
55,300 | |
| Filed 2019-12-06 17:52 Tx date 2019-11-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,890
+1,000 vol $3.89 each |
54,900 | |
| Filed 2019-12-06 17:51 Tx date 2019-11-15 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,558
+2,200 vol $3.89 each |
53,900 | |
| Filed 2019-12-06 17:51 Tx date 2019-11-14 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,700
+3,000 vol $3.90 each |
51,700 | |
| Filed 2019-12-06 17:50 Tx date 2019-11-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$30,000
+8,000 vol $3.75 each |
48,700 | |
| Filed 2019-12-06 17:49 Tx date 2019-11-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,360
+2,400 vol $3.90 each |
40,700 | |
| Filed 2019-12-06 17:44 Tx date 2019-11-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,334
+600 vol $3.89 each |
38,300 | |
| Filed 2019-12-06 17:41 Tx date 2019-11-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Medexus Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$23,560
+6,200 vol $3.80 each |
37,700 | |
| Filed 2019-12-06 17:40 Tx date 2019-11-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Me |